Related Experiment Video
Updated: Jun 23, 2025

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Beyond Death: Unmasking the Intricacies of Apoptosis Escape
Sercan Ergün1,2, Senanur Aslan3, Dilbeste Demir4
1Department of Medical Biology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey. sercanergun@msn.com.
Abstract:
Apoptosis, or programmed cell death, maintains tissue homeostasis by eliminating damaged or unnecessary cells. However, cells can evade this process, contributing to conditions such as cancer. Escape mechanisms include anoikis, mitochondrial DNA depletion, cellular FLICE inhibitory protein (c-FLIP), endosomal sorting complexes required for transport (ESCRT), mitotic slippage, anastasis, and blebbishield formation. Anoikis, triggered by cell detachment from the extracellular matrix, is pivotal in cancer research due to its role in cellular survival and metastasis. Mitochondrial DNA depletion, associated with cellular dysfunction and diseases such as breast and prostate cancer, links to apoptosis resistance. The c-FLIP protein family, notably CFLAR, regulates cell death processes as a truncated caspase-8 form. The ESCRT complex aids apoptosis evasion by repairing intracellular damage through increased Ca2+ levels. Antimitotic agents induce mitotic arrest in cancer treatment but can lead to mitotic slippage and tetraploid cell formation. Anastasis allows cells to resist apoptosis induced by various triggers. Blebbishield formation suppresses apoptosis indirectly in cancer stem cells by transforming apoptotic cells into blebbishields. In conclusion, the future of apoptosis research offers exciting possibilities for innovative therapeutic approaches, enhanced diagnostic tools, and a deeper understanding of the complex biological processes that govern cell fate. Collaborative efforts across disciplines, including molecular biology, genetics, immunology, and bioinformatics, will be essential to realize these prospects and improve patient outcomes in diverse disease contexts.
Insights
Cancer cells evade apoptosis, programmed cell death, through mechanisms like anoikis and c-FLIP. Understanding these escape routes is key for developing new cancer therapies and improving patient outcomes.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Biology
Background:
- Apoptosis, or programmed cell death, is crucial for tissue homeostasis.
- Dysregulation of apoptosis contributes to cancer development and progression.
- Cells employ various escape mechanisms to resist apoptosis.
Purpose of the Study:
- To review the diverse mechanisms by which cells evade apoptosis.
- To highlight the role of these escape mechanisms in cancer.
- To discuss future directions in apoptosis research for therapeutic development.
Main Methods:
- Literature review of apoptosis evasion mechanisms.
- Analysis of the role of anoikis, mitochondrial DNA depletion, c-FLIP, ESCRT, mitotic slippage, anastasis, and blebbishield formation.
- Discussion of implications for cancer research and treatment.
Main Results:
- Identified multiple cellular strategies for apoptosis evasion, including anoikis, mitochondrial dysfunction, c-FLIP, ESCRT, mitotic slippage, anastasis, and blebbishield formation.
- Highlighted the significance of these mechanisms in cancer cell survival, metastasis, and resistance to therapy.
- Detailed the specific roles of key pathways like anoikis and c-FLIP in cancer progression.
Conclusions:
- Apoptosis evasion is a hallmark of cancer, driven by complex cellular mechanisms.
- Targeting these evasion pathways presents promising therapeutic opportunities.
- Interdisciplinary research is essential for advancing apoptosis understanding and clinical applications.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Caspases
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...

